Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.88658325
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...

229.27 -1.56 (-0.68%)

42.53% Gain from 52W Low

300.3K

XNAS Volume

XNAS 22 Jun, 2026 2:46 PM (EDT)

Not Eligible

Expensive Valuation

19.8 / 100

Technically Neutral

55.6 / 100

293

1Yr Price target upside is 28%

18 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..